GSK3 beta mediates suppression of cyclin D2 expression by tumor suppressor PTEN. (Q42834476)

8 November 2017

GSK3 beta mediates suppression of cyclin D2 expression by tumor suppressor PTEN. (English)

1 reference

8 November 2017

W Huang

1

1 reference

8 November 2017

H Y Chang

2

1 reference

8 November 2017

T Fei

3

1 reference

8 November 2017

H Wu

4

1 reference

8 November 2017

Y-G Chen

5

1 reference

8 November 2017

language of work or name

English

0 references

publication date

9 October 2006

1 reference

8 November 2017

1 reference

8 November 2017

26

1 reference

8 November 2017

17

1 reference

8 November 2017

2471-2482

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.onc.1210033

8 November 2017

0 references

cites work

beta-catenin is a target for the ubiquitin-proteasome pathway

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210033

7 January 2021

Pten inactivation alters peripheral B lymphocyte fate and reconstitutes CD19 function

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210033

7 January 2021

Defective thymocyte proliferation and IL-2 production in transgenic mice expressing a dominant-negative form of CREB

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210033

7 January 2021

Phosphorylation of the cAMP response element binding protein CREB by cAMP-dependent protein kinase A and glycogen synthase kinase-3 alters DNA-binding affinity, conformation, and increases net charge

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210033

7 January 2021

Genetic replacement of cyclin D1 function in mouse development by cyclin D2.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210033

7 January 2021

Development of mice expressing a single D-type cyclin.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210033

7 January 2021

Cellular survival: a play in three Akts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210033

7 January 2021

Pten is essential for embryonic development and tumour suppression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210033

7 January 2021

Loss of the tumor suppressor gene PTEN marks the transition from intratubular germ cell neoplasias (ITGCN) to invasive germ cell tumors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210033

7 January 2021

Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210033

7 January 2021

Regulation of neuronal survival by the serine-threonine protein kinase Akt

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210033

7 January 2021

Growth suppression of glioma cells by PTEN requires a functional phosphatase catalytic domain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210033

7 January 2021

Modulation of transcriptional regulation by LEF-1 in response to Wnt-1 signaling and association with beta-catenin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210033

7 January 2021

Identification of a Wnt/Dvl/beta-Catenin --> Pitx2 pathway mediating cell-type-specific proliferation during development

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210033

7 January 2021

Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210033

7 January 2021

Mouse development and cell proliferation in the absence of D-cyclins.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210033

7 January 2021

Cre/loxP-mediated inactivation of the murine Pten tumor suppressor gene.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210033

7 January 2021

PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210033

7 January 2021

Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210033

7 January 2021

Genetic deletion of the Pten tumor suppressor gene promotes cell motility by activation of Rac1 and Cdc42 GTPases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210033

7 January 2021

Targeting the PI3K-Akt pathway in human cancer: rationale and promise

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210033

7 January 2021

The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210033

7 January 2021

Allelic imbalance, including deletion of PTEN/MMACI, at the Cowden disease locus on 10q22-23, in hamartomas from patients with Cowden syndrome and germline PTEN mutation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210033

7 January 2021

Cyclin D2 controls B cell progenitor numbers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210033

7 January 2021

Cyclin D Expression Is Controlled Post-transcriptionally via a Phosphatidylinositol 3-Kinase/Akt-dependent Pathway

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210033

7 January 2021

Germline mutations in the PTEN/MMAC1 gene in patients with Cowden disease.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210033

7 January 2021

Serine phosphorylation-regulated ubiquitination and degradation of beta-catenin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210033

7 January 2021

BCR-ABL and interleukin 3 promote haematopoietic cell proliferation and survival through modulation of cyclin D2 and p27Kip1 expression.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210033

7 January 2021

Tumor suppressor PTEN inhibits nuclear accumulation of beta-catenin and T cell/lymphoid enhancer factor 1-mediated transcriptional activation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210033

7 January 2021

Phosphatidylinositol 3-kinase-dependent mitogen-activated protein/extracellular signal-regulated kinase kinase 1/2 and NF-kappa B signaling pathways are required for B cell antigen receptor-mediated cyclin D2 induction in mature B cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210033

7 January 2021

Gastrin-mediated activation of cyclin D1 transcription involves beta-catenin and CREB pathways in gastric cancer cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210033

7 January 2021

PTEN induces cell cycle arrest by decreasing the level and nuclear localization of cyclin D1.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210033

7 January 2021

Distinct patterns of expression of the D-type cyclins during testicular development in the mouse

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210033

7 January 2021

Hormone-induced proliferation and differentiation of granulosa cells: a coordinated balance of the cell cycle regulators cyclin D2 and p27Kip1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210033

7 January 2021

Cell cycle inhibition by FoxO forkhead transcription factors involves downregulation of cyclin D.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210033

7 January 2021

Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210033

7 January 2021

Phosphatidylinositol 3-kinase/Akt stimulates androgen pathway through GSK3beta inhibition and nuclear beta-catenin accumulation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210033

7 January 2021

CDK inhibitors: positive and negative regulators of G1-phase progression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210033

7 January 2021

Cyclin D2 is an FSH-responsive gene involved in gonadal cell proliferation and oncogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210033

7 January 2021

Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210033

7 January 2021

Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210033

7 January 2021

Essential role of AKT-1/protein kinase B alpha in PTEN-controlled tumorigenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210033

7 January 2021

PTEN modulates cell cycle progression and cell survival by regulating phosphatidylinositol 3,4,5,-trisphosphate and Akt/protein kinase B signaling pathway

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210033

7 January 2021

Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210033

7 January 2021

Regulation of cyclin D2 and the cyclin D2 promoter by protein kinase A and CREB in lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210033

7 January 2021

G1-phase regulators, cyclin D1, cyclin D2, and cyclin D3: up-regulation at gastrulation and dynamic expression during neurulation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210033

7 January 2021

Molecular cloning and chromosomal mapping of CCND genes encoding human D-type cyclins

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210033

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1210033

1 reference

Dimensions Publication ID

8 November 2017

0 references

1 reference